| Ticker Details |
argenx SE
argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases.
|
| IPO Date: |
May 18, 2017 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$50.15B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$4.45 | 1.50%
|
| Avg Daily Range (30 D): |
$12.06 | 1.49%
|
| Avg Daily Range (90 D): |
$10.72 | 1.36%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.21M |
| Avg Daily Volume (30 D): |
.28M |
| Avg Daily Volume (90 D): |
.31M |
| Trade Size |
| Avg Trade Size (Sh.): |
39 |
| Avg Trade Size (Sh.) (30 D): |
21 |
| Avg Trade Size (Sh.) (90 D): |
20 |
| Institutional Trades |
| Total Institutional Trades: |
1,991 |
| Avg Institutional Trade: |
$11.08M |
| Avg Institutional Trade (30 D): |
$27.24M |
| Avg Institutional Trade (90 D): |
$21.35M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$10.89M |
| Avg Closing Trade (30 D): |
$16.73M |
| Avg Closing Trade (90 D): |
$16.25M |
| Avg Closing Volume: |
20.97K |
|
|
|
|
|
